G2 Investment Partners Management LLC purchased a new position in shares of Semler Scientific, Inc. (NASDAQ:SMLR - Free Report) during the 4th quarter, according to its most recent Form 13F filing with the SEC. The fund purchased 30,576 shares of the company's stock, valued at approximately $1,651,000. G2 Investment Partners Management LLC owned approximately 0.33% of Semler Scientific at the end of the most recent reporting period.
Other institutional investors and hedge funds have also recently added to or reduced their stakes in the company. BNP Paribas Financial Markets acquired a new stake in shares of Semler Scientific in the fourth quarter valued at about $30,000. Jones Financial Companies Lllp bought a new position in Semler Scientific in the fourth quarter valued at approximately $34,000. Larson Financial Group LLC acquired a new position in shares of Semler Scientific during the 4th quarter worth approximately $38,000. NewEdge Advisors LLC increased its position in shares of Semler Scientific by 318.3% during the 4th quarter. NewEdge Advisors LLC now owns 732 shares of the company's stock worth $40,000 after purchasing an additional 557 shares during the last quarter. Finally, IFP Advisors Inc bought a new stake in shares of Semler Scientific during the 4th quarter worth approximately $54,000. 49.37% of the stock is owned by institutional investors.
Analyst Upgrades and Downgrades
Separately, Lake Street Capital raised their target price on shares of Semler Scientific from $40.00 to $71.00 and gave the company a "buy" rating in a research note on Friday, January 24th.
Read Our Latest Analysis on Semler Scientific
Semler Scientific Price Performance
SMLR stock traded down $4.31 during trading hours on Wednesday, reaching $32.39. The stock had a trading volume of 1,179,130 shares, compared to its average volume of 433,932. The stock has a 50-day simple moving average of $35.00 and a 200 day simple moving average of $46.72. Semler Scientific, Inc. has a fifty-two week low of $21.77 and a fifty-two week high of $81.56. The stock has a market capitalization of $310.85 million, a PE ratio of 6.60 and a beta of 1.33.
Semler Scientific (NASDAQ:SMLR - Get Free Report) last issued its earnings results on Tuesday, May 13th. The company reported ($0.76) earnings per share (EPS) for the quarter. Semler Scientific had a net margin of 72.65% and a return on equity of 50.77%. The firm had revenue of $8.84 million during the quarter.
About Semler Scientific
(
Free Report)
Semler Scientific, Inc provides technology solutions to enhance the clinical effectiveness and efficiency of healthcare providers in the United States. The company's products include QuantaFlo, a four-minute in-office blood flow test that enables healthcare providers to use blood flow measurements as part of their examinations of a patient's vascular condition.
Read More
Before you consider Semler Scientific, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Semler Scientific wasn't on the list.
While Semler Scientific currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Nuclear energy stocks are roaring. It's the hottest energy sector of the year. Cameco Corp, Paladin Energy, and BWX Technologies were all up more than 40% in 2024. The biggest market moves could still be ahead of us, and there are seven nuclear energy stocks that could rise much higher in the next several months. To unlock these tickers, enter your email address below.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
